The epidemiology of invasive candidiasis has evolved in recent years, warranting a review
of the changes and the implications for current and future diagnosis and treatment. The …

Nisin is a bacteriocin produced by a group of Gram‐positive bacteria that belongs to
Lactococcus and Streptococcus species. Nisin is classified as a Type A (I) lantibiotic that is …

Invasive fungal infections (IFI) are an emerging problem worldwide with invasive candidiasis
and candidemia responsible for the majority of cases. This is predominantly driven by the …

The epidemiology of Candida infections has changed in recent years. Although Candida
albicans is still the main cause of invasive candidiasis in most clinical settings, a substantial …

The incidence of infections caused by Candida species (candidosis) has increased
considerably over the past three decades, mainly due to the rise of the AIDS epidemic, an …

Abstract (See the Editorial Commentary by Clancy and Nguyen, on pages 1123–5.)
Background. Invasive candidiasis (IC) is an important healthcare-related infection, with …

Guidelines for the management of patients with invasive candidiasis and mucosal
candidiasis were prepared by an Expert Panel of the Infectious Diseases Society of America …

Invasive candidiasis (IC) is a leading cause of mycosis-associated mortality in the United
States. We examined data from the National Center for Health Statistics and reviewed recent …

Abstract Background. Nosocomial bloodstream infections (BSIs) are important causes of
morbidity and mortality in the United States. Methods. Data from a nationwide, concurrent …

The incidence of invasive mycoses is increasing, especially among patients who are
immunocompromised or hospitalized with serious underlying diseases. Such infections may …